NPI: 1770551004 · PLANT CITY, FL 33563 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/11/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 03/11/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 11,465 | $2.10M |
| 2019 | 22,080 | $3.84M |
| 2020 | 17,727 | $2.32M |
| 2021 | 9,141 | $722K |
| 2022 | 4,005 | $213K |
| 2023 | 2,047 | $126K |
| 2024 | 1,459 | $76K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 24,341 | 1,619 | $3.35M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 21,736 | 1,114 | $2.62M |
| J1270 | Injection, doxercalciferol, 1 mcg | 10,008 | 690 | $1.50M |
| A4657 | Syringe, with or without needle, each | 3,056 | 1,129 | $712K |
| J1756 | Injection, iron sucrose, 1 mg | 3,635 | 805 | $423K |
| 85041 | 1,084 | 731 | $158K | |
| 85048 | 1,017 | 686 | $158K | |
| 83970 | 820 | 553 | $135K | |
| 83540 | 708 | 509 | $110K | |
| 82728 | 633 | 449 | $96K | |
| 83550 | 636 | 451 | $92K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 197 | 93 | $35K |
| 82746 | 18 | 12 | $3K | |
| 82108 | 17 | 12 | $3K | |
| G0008 | Administration of influenza virus vaccine | 18 | 12 | $2K |